Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
Various vaccine strategies have been proposed in response to the global COVID-19 pandemic, each with unique strategies for eliciting immune responses. Here, we developed nanoparticle vaccines by covalently conjugating the self-assembled 24-mer ferritin to the receptor binding domain (RBD) and/or hep...
Saved in:
Published in | Immunity Vol. 53; no. 6; pp. 1315 - 1330.e9 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article Web Resource |
Language | English |
Published |
United States
Elsevier Inc
15.12.2020
Elsevier BV Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!